NIH launches clinical trials for long COVID; HHS office to coordinate federal response

The National Institutes of Health鈥檚 Researching COVID to Enhance Recovery (RECOVER) Initiative opened enrollment for clinical trials to evaluate the safety and effectiveness of at least four potential treatments for Long COVID in adults. The project expects to launch trials to test at least seven more treatments in coming months, informed by findings from its other research over the past two years.
鈥淩ecognizing that more than one solution is likely needed, we鈥檝e taken the lessons learned from RECOVER participants to design rigorous clinical trial platforms that will identify treatments for persons with different symptom clusters to improve their function and well-being,鈥 Walter Koroshetz, M.D., director of the NIH鈥檚 National Institute of Neurological Disorders and Stroke.
In related news, the Department of Health and Human Services today officially its Office of Long COVID Research and Practice to coordinate and lead the federal response to Long COVID.